https://orcid.org/0000-0003-2681-6641
References
- Sanders DR, Doney K, Poco M; ICL in Treatment of Myopia Study Group. United States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopia: three-year follow-up. Ophthalmology. 2004;111(9):1683–1692.
- Lisa C, Alfonso JF, Alfonso-Bartolozzi B, Fernández-Vega L, Pérez-Vives C, Montés-Micó R. Collagen copolymer posterior chamber phakic intraocular lens supported by the ciliary sulcus to treat myopia: one-year follow-up. J Cataract Refract Surg. 2015;41(1):98–104. doi:10.1016/j.jcrs.2014.05.036
- Sanders DR, Vukich JA. Comparison of implantable contact lens and laser assisted in situ keratomileusis for moderate to high myopia. Cornea. 2003;22(4):324–331. doi:10.1097/00003226-200305000-00009
- Ieong A, Hau SC, Rubin GS, Allan BD. Quality of life in high myopia before and after implantable Collamer lens implantation. Ophthalmology. 2010;117(12):2295–2300. doi:10.1016/j.ophtha.2010.03.055
- Packer M. Meta-analysis and review: effectiveness, safety, and central port design of the intraocular collamer lens. Clin Ophthalmol. 2016;10:1059–1077. doi:10.2147/OPTH.S111620
- Packer M. The implantable collamer lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427–2436. doi:10.2147/OPTH.S188785
- Approval for the EVO/EVO+ Visian implantable collamer lens. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P030016S035. Accessed April 1, 2022.
- Chylack LT Jr, Wolfe JK, Singer DM, et al. The lens opacities classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111(6):831–836. doi:10.1001/archopht.1993.01090060119035
- Visian® TORIC ICL (Implantable Collamer® Lens) for myopia directions for use. https://www.accessdata.fda.gov/cdrh_docs?pdf3/P030016S001d.pdf (Accessed May 19, 2022)
- Ganesh S, Brar S. Comparison of surgical time and IOP spikes with two ophthalmic viscosurgical devices following Visian STAAR (ICL, V4c model) insertion in the immediate postoperative period. Clin Ophthalmol. 2016;10:207–211. doi:10.2147/OPTH.S89487
- Qin Q, Bao L, He Z, et al. Pure ICL implantation: a novel ophthalmic viscosurgical device-free method. J Ophthalmol. 2021;2021:1–11. doi:10.1155/2021/7363267
- Kaufman BJ, Sugar J. Discrete nuclear sclerosis in young patients with myopia. Arch Ophthalmol. 1996;114(10):1178–1180. doi:10.1001/archopht.1996.01100140378001
- Haarman AEG, Enthoven CA, Tideman JWL, Tedja MS, Verhoeven VJM, Klaver CCW. The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61(4):49. doi:10.1167/iovs.61.4.49
- Burton TC. The influence of refractive error and lattice degeneration on the incidence of retinal detachment. Trans Am Ophthalmol Soc. 1989;87:143–55; discussion 155–7.
- Bernheim D, Rouberol F, Palombi K, Albrieux M, Romanet JP, Chiquet C. Comparative prospective study of rhegmatogenous retinal detachments in phakic or pseudophakic patients with high myopia. Retina. 2013;33(10):2039–2048. doi:10.1097/IAE.0b013e31828992ac
- Martínez-Castillo V, Boixadera A, Verdugo A, Elíes D, Coret A, García-Arumí J. Rhegmatogenous retinal detachment in phakic eyes after posterior chamber phakic intraocular lens implantation for severe myopia. Ophthalmology. 2005;112(4):580–585. doi:10.1016/j.ophtha.2004.09.025
- Ruiz-Moreno JM, Montero JA, de la Vega C, Alió JL, Zapater P. Retinal detachment in myopic eyes after phakic intraocular lens implantation. J Refract Surg. 2006;22(3):247–252. doi:10.3928/1081-597X-20060301-09
- Flaxel CJ, Adelman RA, Bailey ST, et al. Posterior vitreous detachment, retinal breaks, and lattice degeneration preferred practice pattern®. Ophthalmology. 2020;127(1):P146–P181. doi:10.1016/j.ophtha.2019.09.027
- Eom Y, Kim DW, Ryu D, et al. Ring-shaped dysphotopsia associated with posterior chamber phakic implantable collamer lenses with a central hole. Acta Ophthalmol. 2017;95(3):e170–e178. doi:10.1111/aos.13248
- Transcript, ophthalmic devices panel of US FDA. Free State Reporting, Inc; 2014.
- STAAR surgical. Available from: https://investors.staar.com/press-releases/press-release-details/2022/STAAR-Surgical-Announces-U.S.-FDA-Approval-of-EVO-Visian-Implantable-Collamer-Lenses/default.aspx. Accessed March 28, 2022.